Isolation of RNA from residual BD SurePath™ liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTect™ HPV-Proofer assay-Reference-Cited by-同舟云学术

Isolation of RNA from residual BD SurePath™ liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTect™ HPV-Proofer assay

Published:2008-12 Issue:1-2 Volume:154 Page:220-222
ISSN:0166-0934
Container-title:Journal of Virological Methods
language:en
Short-container-title:Journal of Virological Methods

Author:

Dixon Eric P.,King Lorraine M.,Adams Melissa D.,Grønn Petter,Murphy Patricia G.,Brown Charlotte A.,Brough George H.,Skomedal Hanne,Malinowski Douglas P.,Fischer Timothy J.

Publisher

Elsevier BV

Subject

Virology

Reference22 articles.

1. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes;Barbosa;Oncogene,1989

2. The causal relation between human papillomavirus and cervical cancer;Bosch;J. Clin. Pathol.,2002

3. Human papillomavirus testing in primary screening for the detection of high grade cervical lesions a study of 7932 women;Clavel;Br. J. Cancer,2001

4. Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18;Cubie;Mol. Pathol.,2001

5. Test performance comparison of inform HPV and hybrid capture 2 high-risk HPV DNA tests using the SurePath liquid-based Pap test as the collection method;Davis-Devine;Am. J. Clin. Pathol.,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of first-void urine with Aptima Transfer Solution increases detection of high-risk HPV E6/E7 mRNA;Journal of Virological Methods;2019-05

2. The potential of RNA as a target for national screening of pre-cancer;Journal of Public Health in Africa;2018-12-21

3. Advances in Molecular Testing Techniques in Cytologic Specimens;Surgical Pathology Clinics;2018-09

4. Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens;Papillomavirus Research;2017-06

5. Reverse transcription-polymerase chain reaction molecular testing of cytology specimens: Pre-analytic and analytic factors;Cancer Cytopathology;2016-07-14